Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for Type 1 Diabetes
Sites in Detroit +6 more locations
Sponsor: Indiana University
Sex: All·Age: 18+
Code: NCT07676565·Recruiting·Listed Jun 2026
Clinical Trials at Henry Ford Hospital
As of August 2026, 136 paid clinical trials are recruiting at Henry Ford Hospital, located at 1 FORD PL, DETROIT, MI 48202-3450, phone (313) 916-2000 in Detroit, Michigan. Active studies at this site cover conditions such as Endometrial Cancer, Advanced Solid Tumor and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Detroit
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
137 clinical trials at Henry Ford Hospital
·Clear filters· Get a weekly email when new trials open in Detroit, MI.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Detroit, Flint +110 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Detroit, Ann Arbor +69 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
Sites in Detroit, Utica +71 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07220083·Phase 3·Recruiting·Listed Oct 2025
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for HER2-positive Breast Cancer
Sites in Detroit +28 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07102381·Phase 2·Recruiting·Listed Aug 2025
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Detroit, Ann Arbor +65 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
Drug: Remibrutinib
Sites in Detroit, Troy +127 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
Sites in Detroit, Ypsilanti +121 more locations
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sites in Detroit, Grand Rapids +53 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Drug: Giredestrant
Sites in Detroit +46 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06065748·Phase 3·Recruiting·Listed Oct 2023
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Detroit, Ann Arbor +78 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for COVID-19 Infection
Sites in Detroit, Ann Arbor +64 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07013474·Phase 3·Recruiting·Listed Jun 2025
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for Refractory Angina
Sites in Detroit, Southfield +64 more locations
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT05102019·Recruiting·Listed Nov 2021
Pelacarsen Roll-over Extension Program
for Atherosclerotic Cardiovascular Disease
Drug: Pelacarsen
Sites in Detroit, Flint +73 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT06875973·Phase 3·Recruiting·Listed Mar 2025
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
for Melanoma
Sites in Detroit +57 more locations
Sponsor: Pfizer
Sex: All·Age: 16+
Code: NCT05538130·Phase 1·Recruiting·Listed Sep 2022
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in Detroit, Ann Arbor +47 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
Drug: riliprubart
Sites in Detroit, East Lansing +31 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06290141·Phase 3·Recruiting·Listed Mar 2024
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for Coronary Arterial Disease (CAD)
Sites in Detroit, Ann Arbor +43 more locations
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT06959524·Recruiting·Listed May 2025
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for Heart Failure
Sites in Detroit +82 more locations
Sponsor: Cytokinetics
Sex: All·Age: 18 - 85
Code: NCT06736574·Phase 3·Recruiting·Listed Dec 2024
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for Hypertension
Sites in Detroit, Southfield +31 more locations
Sponsor: SoniVie Inc.
Sex: All·Age: 22 - 75
Code: NCT06559891·Recruiting·Listed Aug 2024
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for Non Small Cell Lung Carcinoma
Sites in Detroit +23 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06772623·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
Sites in Detroit, Ann Arbor +44 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for Chronic Graft-versus-host-disease
Sites in Detroit, Ann Arbor +34 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 12+
Code: NCT06585774·Phase 3·Recruiting·Listed Sep 2024
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for Immunoglobulin A Nephropathy (IgAN)
Sites in Detroit +23 more locations
Sponsor: Biogen
Sex: All·Age: 18+
Code: NCT06935357·Phase 3·Recruiting·Listed Apr 2025
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
Sites in Detroit +41 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
for Heart Failure
Sites in Detroit, Grand Rapids +55 more locations
Sponsor: Abbott Medical Devices
Sex: All·Age: 18+
Code: NCT06526195·Recruiting·Listed Jul 2024
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for Aortic Stenosis
Sites in Detroit, Ann Arbor +69 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18 - 105
Code: NCT06777368·Recruiting·Listed Jan 2025
The THOR IDE Study
for Peripheral Artery Disease
Sites in Detroit +28 more locations
Sponsor: Philips Clinical & Medical Affairs Global
Sex: All·Age: 18+
Code: NCT05916950·Recruiting·Listed Jun 2023
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for Aortic Stenosis
Drug: Pelacarsen
Sites in Detroit, Royal Oak +31 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 50 - 80
Code: NCT05646381·Phase 2·Recruiting·Listed Dec 2022
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
Drug: Ruxolitinib
Sites in Detroit, Ann Arbor +28 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for Chronic Lymphocytic Leukemia
Drug: Venetoclax
Sites in Detroit +30 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06428019·Phase 3·Recruiting·Listed May 2024
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
for Chronic Graft-versus-host-disease
Sites in Detroit +12 more locations
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 2+
Code: NCT04710576·Phase 2·Recruiting·Listed Jan 2021
PARTNER 3 Trial - Aortic Valve-in-Valve
for Aortic Stenosis
Sites in Detroit +28 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT03003299·Recruiting·Listed Dec 2016
Impella RP Flex with Smart Assist
for Right Ventricular (RV) Dysfunction
Sites in Detroit +30 more locations
Sponsor: Abiomed Inc.
Sex: All·Age: All ages
Code: NCT06637644·Recruiting·Listed Oct 2024
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Sites in Detroit +22 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07266831·Phase 2, Phase 3·Recruiting·Listed Dec 2025
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
for Myasthenia Gravis
Drug: Nipocalimab
Sites in Detroit +13 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 74
Code: NCT07217587·Phase 3·Recruiting·Listed Oct 2025
ATLAS (AltaValve) Pivotal Trial
for Mitral Regurgitation
Sites in Detroit, Royal Oak +34 more locations
Sponsor: 4C Medical Technologies, Inc.
Sex: All·Age: 18+
Code: NCT06465745·Recruiting·Listed Jun 2024
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for Metastatic Breast Cancer
Sites in Detroit +15 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT05894239·Phase 3·Recruiting·Listed Jun 2023
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for Autoimmune Haemolytic Anaemia
Sites in Detroit, Ann Arbor +21 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07086976·Phase 3·Recruiting·Listed Jul 2025
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for Breast Neoplasms
Sites in Detroit +8 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05386108·Phase 1, Phase 2·Recruiting·Listed May 2022
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for Advanced Solid Tumors
Sites in Detroit +11 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT05719558·Phase 1·Recruiting·Listed Feb 2023
Common conditions studied in Detroit
- Endometrial Cancer (14 active studies)
- Advanced Solid Tumor (13 active studies)
- Breast Cancer (13 active studies)
- Heart Failure (13 active studies)
- Multiple Myeloma (12 active studies)
- Ovarian Cancer (12 active studies)
Leading research sponsors in Detroit
- Henry Ford Health System
- National Cancer Institute (NCI)
- AstraZeneca
- Wayne State University
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Detroit?
There are approximately 718 recruiting clinical trials in Detroit, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Detroit pay participants?
Most recruiting trials in Detroit compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Detroit?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Detroit?
The most common conditions under active study in Detroit include Endometrial Cancer (14), Advanced Solid Tumor (13), Breast Cancer (13), Heart Failure (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Detroit?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Detroit on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Detroit?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Detroit?
Recruiting research sites in Detroit include Henry Ford Hospital, Karmanos Cancer Institute, Henry Ford Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Detroit right now?
The largest active categories in Detroit are Cancer & tumors (305), Cardiovascular (51), Neurology & pain (26). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Henry Ford Hospital?
Henry Ford Hospital is located at 1 FORD PL, DETROIT, MI 48202-3450. Use the Google Maps link in the intro above to get directions.
How do I contact Henry Ford Hospital?
You can reach Henry Ford Hospital by phone at (313) 916-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Michigan
Ann Arbor, MI(971)Grand Rapids, MI(421)Flint, MI(140)Lansing, MI(134)Ypsilanti, MI(134)Farmington Hills, MI(115)Brighton, MI(101)Royal Oak, MI(100)Troy, MI(100)Livonia, MI(98)Kalamazoo, MI(96)Chelsea, MI(89)Pontiac, MI(89)Canton, MI(87)Wyoming, MI(84)Dearborn, MI(71)Southfield, MI(71)Traverse City, MI(71)Novi, MI(68)Saginaw, MI(63)Saint Joseph, MI(57)Clinton Township, MI(56)Battle Creek, MI(54)Clarkston, MI(53)Reed City, MI(53)West Bloomfield, MI(49)Niles, MI(48)Tawas City, MI(48)Macomb, MI(45)Warren, MI(44)Grosse Pointe Woods, MI(39)Midland, MI(36)Jackson, MI(35)Brownstown, MI(34)Bay City, MI(31)Mount Pleasant, MI(31)Sterling Heights, MI(31)Wyandotte, MI(31)Escanaba, MI(30)Muskegon, MI(30)East China Township, MI(28)East Lansing, MI(24)Alma, MI(21)Alpena, MI(20)Gladwin, MI(20)Petoskey, MI(20)Lapeer, MI(19)Norton Shores, MI(19)Saint Clair Shores, MI(17)Bloomfield Hills, MI(15)Port Huron, MI(15)Rochester Hills, MI(15)Mount Clemens, MI(13)Auburn Hills, MI(12)Grand Blanc, MI(12)Waterford, MI(10)Shelby, MI(9)Allen Park, MI(8)Caledonia, MI(7)Dearborn Heights, MI(7)